Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Cystic Fibrosis

• Publication date

  2004-08-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/J.JCF.2004.03.010PMID 15463902
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Basic molecular biology.

  2005cited by this paper
• Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission.

  2003cited by this paper
• The pathology of cystic fibrosis

  2002cited by this paper
• Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada.

  2002cited by this paper
• Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.

  2001cited by this paper
• Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis

  2001cited by this paper
• Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa.

  2001cited by this paper
• Molecular epidemiology of community-acquired Staphylococcus aureus in families with and without cystic fibrosis patients.

  2000cited by this paper
• Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

  2000cited by this paper
• Long-term outbreak of a transmissable virulent strain of Pseudomonas aeruginosa in a paediatric cystic fibrosis clinic

  2000cited by this paper
• Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centre.

  1998cited by this paper
• Methicillin-resistant Staphylococcus aureus in a cystic fibrosis unit.

  1997cited by this paper
• Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting

  1996cited by this paper
• Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward

  1996cited by this paper
• The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain

  1995cited by this paper
• Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing

  1995cited by this paper
• Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa

  1995cited by this paper
• Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis.

  1993cited by this paper
• Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission

  1993cited by this paper
• Pseudomonas aeruginosa as an Opportunistic Pathogen

  1993cited by this paper
• Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients

  1993cited by this paper
• Ecology and Epidemiologyof Pseudomonas aeruginosa

  1993cited by this paper
• Generation of Pseudomonas aeruginosa aerosols during handwashing from contaminated sink drains, transmission to hands of hospital personnel, and its prevention by use of a new heating device.

  1991cited by this paper
• DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak

  1991cited by this paper
• Genomic DNA fingerprinting by pulsed-field gel electrophoresis as an epidemiological marker for study of nosocomial infections caused by methicillin-resistant Staphylococcus aureus

  1991cited by this paper
• Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients

  1991influential reference
• Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.

  1990cited by this paper
• Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe

  1989cited by this paper
• Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains

  1988cited by this paper
• Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes.

  1987cited by this paper
• An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre.

  1986cited by this paper

• Biofilm-mediated infections by multidrug-resistant microbes: a comprehensive exploration and forward perspectives

  2024cites this paper
• Glycerol metabolism impacts biofilm phenotypes and virulence in Pseudomonas aeruginosa via the Entner-Doudoroff pathway

  2024cites this paper
• Medicinal plant Miconia albicans synergizes with ampicillin and ciprofloxacin against multi-drug resistant Acinetobacter baumannii and Staphylococcus aureus

  2023cites this paper
• PtsN in Pseudomonas aeruginosa Is Phosphorylated by Redundant Upstream Proteins and Impacts Virulence-Related Genes

  2023cites this paper
• Prevalence of carbapenemase genes among multidrug-resistant Pseudomonas aeruginosa isolates from tertiary care centers in Southern Thailand

  2022cites this paper
• Antimicrobial susceptibility and genotyping of microorganisms isolated from sputum culture of children with cystic fibrosis in an Iranian referral children’s hospital

  2022cites this paper
• MRSA strains with distinct accessory genes predominate at different ages in cystic fibrosis

  2021cites this paper
• Profiling structural diversity and activity of 2-alkyl-4(1H)-quinolone N-oxides of Pseudomonas and Burkholderia.

  2020cites this paper
• The biofilm‐associated bacterial infections unrelated to indwelling devices

  2020cites this paper
• Factors influencing the acquisition and eradication of early Pseudomonas aeruginosa infection in cystic fibrosis.

  2020cites this paper
• Prevalence of Methicillin-Resistant Staphylococcus Aureus (MRSA) infection in patients with Cystic Fibrosis: a meta-analysis

  2019cites this paper
• Folding–function relationship of the most common cystic fibrosis–causing CFTR conductance mutants

  2019cites this paper
• Impact of underlying cause of bronchiectasis on clinical outcome: A comparative study on CF and Non-CF bronchiectasis in Egyptian children

  2018cites this paper
• Modelling and simulating twitching bacteria and phytoglycogen nanoparticles

  2018cites this paper
• Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function

  2018cites this paper
• Impact of underlying cause of bronchiectasis on clinical outcome: A comparative study on CF and Non-CF bronchiectasis in Egyptian children

  2018cites this paper
• Molecular Detection of virulence factor genes in pseudomonas aeruginosa isolated from human and animals in Diwaniya province

  2017cites this paper
• Essential Oil from Origanum vulgare Completely Inhibits the Growth of Multidrug-Resistant Cystic Fibrosis Pathogens

  2016cites this paper
• Molecular Characterization Of Pseudomonas Aeruginosa Clinical Isolates Among Patients Of The Hospital Del Niño, Republic Of Panama

  2016cites this paper
• The art of persistence-the secrets to Burkholderia chronic infections.

  2016influential citation
• Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis

  2016cites this paper
• Bicyclic brominated furanones: a new class of quorum sensing modulators that inhibit bacterial biofilm formation.

  2014cites this paper
• Vitamin D insufficiency in cystic fibrosis : prevalence, consequences and intervention

  2014cites this paper
• ACOMPANHAMENTO FARMACOTERAPÊUTICO DE PACIENTES COM FIBROSE CÍSTICA NA INTERNAÇÃO PEDIÁTRICA DO HOSPITAL DE CLÍNICAS DE PORTO ALEGRE

  2013cites this paper
• Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review

  2013cites this paper
• Structural Stability of Burkholderia cenocepacia Biofilms Is Reliant on eDNA Structure and Presence of a Bacterial Nucleic Acid Binding Protein

  2013influential citation
• I. Stereochemical Control of Chiral Assembly and Liquid Crystal Phase Formation of Nonamphiphilic Molecules in Water II. Control Bacterial Quorum Sensing and Quorum Sensing-mediated Activities Using Small Unnatural Molecules

  2013cites this paper
• [Analysis of the frequency of isolation and drug resistance of microorganisms isolated from the airways of adult CF patients treated in the Institute of Tuberculosis and Lung Disease during 2008-2011].

  2013cites this paper
• CFTR biomarkers: time for promotion to surrogate end-point

  2012cites this paper
• Innate immunity in cystic fibrosis lung disease.

  2012cites this paper
• FRUITS TO POTENTIATE THE ANTIBIOTIC ACTIVITY: THE EFFECT OF EUGENIA UNIFLORA AND EUGENIA JAMBOLANUM L. AGAINST MRSA

  2012cites this paper
• Synergism of Gentamicin and Norfloxacin with the Volatile Compounds of Lippia microphylla Cham. (Verbenaceae)

  2011cites this paper
• Italian national survey on molecular epidemiology of Pseudomonas aeruginosa from pulmonary infection of Cystic Fibrosis patients

  2011cites this paper
• Antibiofilm activity of Andrographis paniculata against cystic fibrosis clinical isolate Pseudomonas aeruginosa

  2011cites this paper
• Molecular Identification of Burkholderia Cepacia Complex and Species Distribution Among Cystic Fibrosis Patients Seen at the Reference Center in Southern Brazil

  2011cites this paper
• The Clinical Utility of Molecular Typing of Multiply-resistant Pseudomonas aeruginosa in Children with Cystic Fibrosis

  2010cites this paper
• Methicillin resistance and vancomycin heteroresistance in Staphylococcus aureus in cystic fibrosis patients

  2010cites this paper
• Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data

  2010cites this paper
• Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia

  2010cites this paper
• The impact of the leather manufacturing process on bacterial growth

  2010influential citation
• Das N-(3-Oxododecanoyl)-L-Homoserinlacton von Pseudomonas aeruginosa inhibiert Funktionen humaner dendritischer Zellen

  2010cites this paper
• Use of Aromatherapy Associated with Antibiotictherapy: Modulation of the Antibiotic Activity by the Essential Oil of Zanthoxylum articulatum Using Gaseous Contact

  2010cites this paper
• Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients

  2009cites this paper
• Cystic fibrosis infections: treatment strategies and prospects.

  2009cites this paper
• Synergy effects of the antibiotics gentamicin and the essential oil of Croton zehntneri.

  2009cites this paper
• Agentes bacterianos pulmonares y terapia antibiótica en pacientes con fibrosis quística: guía para el personal sanitario

  2009cites this paper
• Universidade Federal do Rio Grande do Sul Faculdade de Medicina Programa de pós-graduação em Medicina: Ciências Médicas Variantes Genômicas do complexo Burkholderia cepacia em Pacientes com Fibrose Cística no Hospital de Clínicas de Porto Alegre

  2009cites this paper
• Invitro interactionsoftobramycinwithvariousnonantibiotics againstPseudomonasaeruginosa andBurkholderia cenocepacia

  2008cites this paper
• In vitro activity of tobramycin, amilorides and other non-antibiotics against Pseudomonas aeruginosa and Burkholderia cenocepacia

  2008cites this paper
• Application and evaluation of double digest selective label (DDSL) typing technique for Pseudomonas aeruginosa hospital isolates.

  2008cites this paper
• Usefulness of Sau‐PCR for molecular epidemiology of nosocomial outbreaks due to Burkholderia cepacia which occurred in a local hospital in Guangzhou, China

  2008cites this paper
• In vitro interactions of tobramycin with various nonantibiotics against Pseudomonas aeruginosa and Burkholderia cenocepacia.

  2008cites this paper
• Signal transducer and activator of transcription 4 (STAT4), but not IL-12 contributes to Pseudomonas aeruginosa-induced lung inflammation in mice.

  2008cites this paper
• High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation.

  2008influential citation
• Safety and Efficacy of Long-Term Treatment with Linezolid in Cystic Fibrosis: Case Report

  2008cites this paper
• Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers

  2008cites this paper
• Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway.

  2008cites this paper
• The UK Cystic Fibrosis Trust Infection Control Working Group

  2008cites this paper
• In Vitro and In Vivo Activities of a New Cephalosporin, FR264205, against Pseudomonas aeruginosa (cid:1)

  2007cites this paper
• Pseudomonas aeruginosa and the host pulmonary immune response

  2007cites this paper
• Cystic Fibrosis and Formes Frustes of CFTR-Related Disease

  2007cites this paper
• Diversity of the basic defect of homozygous CFTR mutation genotypes in humans

  2007cites this paper
• Multiple-Locus Variable-Number Tandem-Repeat Analysis for Longitudinal Survey of Sources of Pseudomonas aeruginosa Infection in Cystic Fibrosis Patients †

  2007cites this paper
• Multiple-Locus Variable-Number Tandem-Repeat Analysis for Longitudinal Survey of Sources of Pseudomonas aeruginosa Infection in Cystic Fibrosis Patients

  2007influential citation
• Multidrug–resistant organisms in cystic fibrosis: management and infection–control issues

  2006cites this paper
• In Vitro and In Vivo Activities of a New Cephalosporin, FR264205, against Pseudomonas aeruginosa

  2006cites this paper
• ExsE, a secreted regulator of type III secretion genes in Pseudomonas aeruginosa

  2005cites this paper